These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31146704)

  • 1. Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.
    Kikuchi-Koike R; Nagasaka K; Tsuda H; Ishii Y; Sakamoto M; Kikuchi Y; Fukui S; Miyagawa Y; Hiraike H; Kobayashi T; Kinoshita T; Kanai Y; Shibata T; Imoto I; Inazawa J; Matsubara O; Ayabe T
    BMC Cancer; 2019 May; 19(1):521. PubMed ID: 31146704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.
    Isola JJ; Kallioniemi OP; Chu LW; Fuqua SA; Hilsenbeck SG; Osborne CK; Waldman FM
    Am J Pathol; 1995 Oct; 147(4):905-11. PubMed ID: 7573366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases.
    Vollebergh MA; Klijn C; Schouten PC; Wesseling J; Israeli D; Ylstra B; Wessels LF; Jonkers J; Linn SC
    PLoS One; 2014; 9(8):e103177. PubMed ID: 25083859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype.
    Lee K; Jang MH; Chung YR; Lee Y; Kang E; Kim SW; Kim YJ; Kim JH; Kim IA; Park SY
    Hum Pathol; 2017 Mar; 61():111-120. PubMed ID: 27989787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression Potential of Ductal Carcinoma in situ Assessed by Genomic Copy Number Profiling.
    Kitamura M; Nakayama T; Mukaisho KI; Mori T; Umeda T; Moritani S; Kushima R; Tani M; Sugihara H
    Pathobiology; 2019; 86(2-3):92-101. PubMed ID: 30332671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
    Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.
    Bonnet F; Guedj M; Jones N; Sfar S; Brouste V; Elarouci N; Banneau G; Orsetti B; Primois C; de Lara CT; Debled M; de Mascarel I; Theillet C; Sévenet N; de Reynies A; MacGrogan G; Longy M
    BMC Med Genomics; 2012 Nov; 5():54. PubMed ID: 23186559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.
    Loo LW; Wang Y; Flynn EM; Lund MJ; Bowles EJ; Buist DS; Liff JM; Flagg EW; Coates RJ; Eley JW; Hsu L; Porter PL
    Breast Cancer Res Treat; 2011 May; 127(1):297-308. PubMed ID: 21264507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients.
    Ronowicz A; Janaszak-Jasiecka A; Skokowski J; Madanecki P; Bartoszewski R; Bałut M; Seroczyńska B; Kochan K; Bogdan A; Butkus M; Pęksa R; Ratajska M; Kuźniacka A; Wasąg B; Gucwa M; Krzyżanowski M; Jaśkiewicz J; Jankowski Z; Forsberg L; Ochocka JR; Limon J; Crowley MR; Buckley PG; Messiaen L; Dumanski JP; Piotrowski A
    Hum Mutat; 2015 Nov; 36(11):1088-99. PubMed ID: 26219265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer.
    Suelmann BBM; Rademaker A; van Dooijeweert C; van der Wall E; van Diest PJ; Moelans CB
    Cell Oncol (Dordr); 2022 Aug; 45(4):591-600. PubMed ID: 35792986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer.
    Chao HH; He X; Parker JS; Zhao W; Perou CM
    PLoS One; 2012; 7(12):e51719. PubMed ID: 23284754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach.
    Srihari S; Kalimutho M; Lal S; Singla J; Patel D; Simpson PT; Khanna KK; Ragan MA
    Mol Biosyst; 2016 Mar; 12(3):963-72. PubMed ID: 26805938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization.
    Yoshioka S; Tsukamoto Y; Hijiya N; Nakada C; Uchida T; Matsuura K; Takeuchi I; Seto M; Kawano K; Moriyama M
    PLoS One; 2013; 8(2):e56165. PubMed ID: 23457519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of metaplastic squamous cell carcinoma of the breast inter- and intratumoral heterogeneity.
    Oikawa M; Igawa A; Taguchi K; Baba K; Ishida M; Akiyoshi S; Yano H; Nagayasu T; Ohno S; Tokunaga E
    Breast Cancer; 2017 Nov; 24(6):733-741. PubMed ID: 28316008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.
    Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S
    Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.